Moying Yin

4.7k total citations · 2 hit papers
22 papers, 3.9k citations indexed

About

Moying Yin is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Moying Yin has authored 22 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Hematology and 6 papers in Genetics. Recurrent topics in Moying Yin's work include DNA Repair Mechanisms (6 papers), Acute Myeloid Leukemia Research (5 papers) and TGF-β signaling in diseases (4 papers). Moying Yin is often cited by papers focused on DNA Repair Mechanisms (6 papers), Acute Myeloid Leukemia Research (5 papers) and TGF-β signaling in diseases (4 papers). Moying Yin collaborates with scholars based in United States, Italy and Netherlands. Moying Yin's co-authors include Thomas Doetschman, Sharon A. Pawlowski, Gabriele Proetzel, Ilona Ormsby, Ronald J. Diebold, Ruth D. Allen, C L Sidman, Ann B. Kier, Marcia M. Shull and Gregory P. Boivin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Moying Yin

22 papers receiving 3.8k citations

Hit Papers

Targeted disruption of the mouse transforming growth fact... 1992 2026 2003 2014 1992 1995 500 1000 1.5k 2.0k

Peers

Moying Yin
Sharon A. Pawlowski United States
Gabriele Proetzel United States
Ilona Ormsby United States
Ronald J. Diebold United States
Marcia M. Shull United States
Virginia C. Broudy United States
Ruth D. Allen United States
Feng‐Chun Yang United States
Su‐Li Cheng United States
Michael B. Sporn United States
Sharon A. Pawlowski United States
Moying Yin
Citations per year, relative to Moying Yin Moying Yin (= 1×) peers Sharon A. Pawlowski

Countries citing papers authored by Moying Yin

Since Specialization
Citations

This map shows the geographic impact of Moying Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moying Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moying Yin more than expected).

Fields of papers citing papers by Moying Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moying Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moying Yin. The network helps show where Moying Yin may publish in the future.

Co-authorship network of co-authors of Moying Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Moying Yin. A scholar is included among the top collaborators of Moying Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moying Yin. Moying Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Myer, David L., Moying Yin, Gregory P. Boivin, et al.. (2011). Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 714(1-2). 1–10. 20 indexed citations
2.
Bahassi, El Mustapha, Moying Yin, Yaqin Li, et al.. (2011). A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosis. Cell Division. 6(1). 4–4. 7 indexed citations
3.
Meyer, Sara E., Belinda E. Peace, El Mustapha Bahassi, et al.. (2010). Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Letters. 296(2). 186–193. 4 indexed citations
4.
Azhar, Mohamad, Moying Yin, Ramireddy Bommireddy, et al.. (2009). Generation of mice with a conditional allele for transforming growth factor beta 1 gene. genesis. 47(6). 423–431. 40 indexed citations
5.
Bahassi, El Mustapha, Moying Yin, Gregory P. Boivin, et al.. (2009). Mice with the CHEK2 *1100delC SNP are predisposed to cancer with a strong gender bias. Proceedings of the National Academy of Sciences. 106(40). 17111–17116. 29 indexed citations
6.
Azhar, Mohamad, Moying Yin, Ming Zhou, et al.. (2008). Gene targeted ablation of high molecular weight fibroblast growth factor‐2. Developmental Dynamics. 238(2). 351–357. 25 indexed citations
7.
Yin, Moying, et al.. (2006). Expression and loss of alleles in cultured mouse embryonic fibroblasts and stem cells carrying allelic fluorescent protein genes. BMC Molecular Biology. 7(1). 36–36. 11 indexed citations
8.
Bahassi, El Mustapha, Elisia D. Tichy, Moying Yin, et al.. (2006). The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 616(1-2). 201–209. 21 indexed citations
9.
Bommireddy, Ramireddy, Vijay Saxena, Ilona Ormsby, et al.. (2003). TGF-β1 Regulates Lymphocyte Homeostasis by Preventing Activation and Subsequent Apoptosis of Peripheral Lymphocytes. The Journal of Immunology. 170(9). 4612–4622. 63 indexed citations
10.
Bommireddy, Ramireddy, Ilona Ormsby, Moying Yin, et al.. (2003). TGFβ1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes. The Journal of Immunology. 170(7). 3645–3652. 36 indexed citations
11.
Shao, Changshun, Moying Yin, Li Deng, et al.. (2002). Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2−/− mice. Oncogene. 21(18). 2840–2845. 18 indexed citations
12.
Hoying, James B., Moying Yin, Ronald J. Diebold, et al.. (1999). Transforming Growth Factor β1 Enhances Platelet Aggregation through a Non-transcriptional Effect on the Fibrinogen Receptor. Journal of Biological Chemistry. 274(43). 31008–31013. 40 indexed citations
13.
Zhou, Ming, Roy L. Sutliff, Richard J. Paul, et al.. (1998). Fibroblast growth factor 2 control of vascular tone. Nature Medicine. 4(2). 201–207. 295 indexed citations
14.
Proetzel, Gabriele, Sharon A. Pawlowski, Michael V. Wiles, et al.. (1995). Transforming growth factor–β3 is required for secondary palate fusion. Nature Genetics. 11(4). 409–414. 759 indexed citations breakdown →
15.
Preisler, Harvey D., et al.. (1993). Effects of rhGM-CSF on Myeloid Clonogenic Cells in Acute Myelogenous Leukemia Patients. Leukemia & lymphoma. 10(3). 183–186. 2 indexed citations
16.
Yin, Moying, Federico Silvestri, Shripad Banavali, et al.. (1993). Clonogenic potential of myeloid leukaemia cells in vitro is restricted to leukaemia cells expressing the CD34 antigen. European Journal of Cancer. 29(16). 2279–2283. 8 indexed citations
17.
Shull, Marcia M., Ilona Ormsby, Ann B. Kier, et al.. (1992). Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359(6397). 693–699. 2482 indexed citations breakdown →
18.
Silvestri, Federico, et al.. (1992). Comparison of Two Methods for Concentrating CD34 + Cells from Patients with Acute Non-Lymphocytic Leukemia. Leukemia & lymphoma. 8(4-5). 389–396. 2 indexed citations
19.
Yin, Moying, et al.. (1991). Effects of rGM‐CSF on leukemia cell proliferation and on the incorporation of cytosine arabinoside into DNA. Cell Biochemistry and Function. 9(3). 155–161. 2 indexed citations
20.
Yin, Moying, et al.. (1990). Proto-oncogene expression in differentiating and non-differentiating chronic myelogenous leukaemia cells. European Journal of Cancer and Clinical Oncology. 26(6). 694–698. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026